Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: Am J Manag Care. 2016 May;22(6 Spec No):SP198–SP204.

Figure 1.

Figure 1

Outcomes per site

Virologic breakthrough : A virologic breakthrough is appearance of HCV RNA while patient is still on HCV therapy, Relapse : A relapse was defined as recurrence of HCV RNA in a patient who had an end-of-treatment response (EOTR or undetectable HCV RNA at the end of treatment)